全球哺乳期与产后恢复药用植物调查:进化视角与当代健康意义
该研究汇编全球4418条使用报告涉及1948种植物,其中105个分类群被记录≥7次,最常引用的是小茴香(81次)、葫芦巴(64次)、茴芹(42次)、飞扬草(40次)和总序天冬(38次)。对20种最常引用植物的科学文献评估显示,18/20的植物风险/获益评估支持正向免疫调节潜力超过安全担忧,但已发表证据不支持几乎所有最常引用植物的催乳增强效应,且多数植物的抗抑郁数据主要限于动物研究。
要点
- 全球产后植物使用模式存在地区差异,如北非/中东偏好产胶植物而其他地区偏好芳香烹饪植物。
- 小茴香、葫芦巴、茴芹、飞扬草和总序天冬是记录频率最高的五种植物。
- 18/20最常引用植物的风险/获益评估支持正向免疫调节潜力超过安全担忧。
核心结论
- 在生物文化背景下,传统产后植物使用对母婴二元体具有适应性功能,并提供当代饮食中缺乏的植物化学物,可能影响过敏、炎症等状况。
- 多酚类等植物化学物具有广泛免疫活性,存在于母乳中且主要无毒。
- 除非特定植物被明确证明有害,否则全面建议反对哺乳期产后使用草药在实证上似乎不合理。
研究设计与样本
- 研究基于已发表的催乳剂和产后恢复实践综述与调查,以及全球民族植物学研究,用于识别和排名植物并确定区域使用模式。
- 对基于出版频率最常引用的20种植物,评估了其抗菌、抗氧化、抗炎、免疫调节、抗抑郁、镇痛、催乳和安全性方面的科学文献。
主要发现
- 从4418条使用报告(涉及1948种)中,105个植物分类群被记录≥7次。
- 最常引用物种为小茴香(81次)、葫芦巴(64次)、茴芹(42次)、飞扬草(40次)和总序天冬(38次)。
- 物种和使用全球存在差异,例如北非/中东和撒哈拉以南非洲分别以产胶植物和芳香烹饪植物为主,呈现相反优势模式。
- 对18/20的植物,风险/获益视角支持正向免疫调节及相关潜力超过任何安全担忧。
- 已发表证据不支持几乎所有最常引用植物的催乳增强效应,且大多数植物的抗抑郁数据主要限于动物研究。
关键数值与推荐
- 105个植物分类群被记录≥7次。
- 小茴香、葫芦巴、茴芹、飞扬草和总序天冬分别被引用81、64、42、40和38次。
- 18/20的最常引用植物风险/获益评估支持正向免疫调节潜力超过安全担忧。
临床怎么用
- 临床应关注产后植物使用对母婴的潜在免疫调节和健康贡献,而非全面禁止。
- 草药-药物相互作用和其他不良反应应始终是产科建议的核心,但除非特定植物被明确证明有害,否则不应 blanket 反对哺乳期产后草药使用。
- 需要系统分析人乳、婴儿肠腔和血浆中的植物化学物,并进行区分哺乳期母亲摄入与妊娠期的免疫调节研究。
局限性
- 已发表证据不支持几乎所有最常引用植物的催乳增强效应,且大多数植物的抗抑郁数据主要限于动物研究。
- 需要系统分析人乳、婴儿肠腔和血浆中的植物化学物,并进行区分哺乳期母亲摄入与妊娠期的免疫调节研究。
- 潜在的草药-药物相互作用和其他不良反应应继续作为产科建议的核心关注点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Cross-cultural comparison of plants used during lactation and the postpartum period offers insight into a largely overlooked area of ethnopharmacological research. Potential roles of phytochemicals in emerging models of interaction among immunity, inflammation, microbiome and nervous system effects on perinatal development have relevance for the life-long health of individuals and of populations in both traditional and contemporary contexts. AIM OF THE STUDY: Delineate and interpret patterns of traditional and contemporary global use of medicinal plants ingested by mothers during the postpartum period relative to phytochemical activity on immune development and gastrointestinal microbiome of breastfed infants, and on maternal health. MATERIALS AND METHODS: Published reviews and surveys on galactagogues and postpartum recovery practices plus ethnobotanical studies from around the world were used to identify and rank plants, and ascertain regional use patterns. Scientific literature for 20 most-cited plants based on frequency of publication was assessed for antimicrobial, antioxidant, anti-inflammatory, immunomodulatory, antidepressant, analgesic, galactagogic and safety properties. RESULTS: From compilation of 4418 use reports related to 1948 species, 105 plant taxa were recorded ≥7 times, with the most frequently cited species, Foeniculum vulgare, Trigonella foenum-graecum, Pimpinella anisum, Euphorbia hirta and Asparagus racemosus, 81, 64, 42, 40 and 38 times, respectively. Species and use vary globally, illustrated by the pattern of aromatic plants of culinary importance versus latex-producing plants utilized in North Africa/Middle East and Sub-Saharan Africa with opposing predominance. For 18/20 of the plants a risk/benefit perspective supports assessment that positive immunomodulation and related potential exceed any safety concerns. Published evidence does not support a lactation-enhancing effect for nearly all the most-cited plants while antidepressant data for the majority of plants are predominately limited to animal studies. CONCLUSIONS: Within a biocultural context traditional postpartum plant use serves adaptive functions for the mother-infant dyad and contributes phytochemicals absent in most contemporary diets and patterns of ingestion, with potential impacts on allergic, inflammatory and other conditions. Polyphenolics and other phytochemicals are widely immunologically active, present in breast milk and predominately non-toxic. Systematic analysis of phytochemicals in human milk, infant lumen and plasma, and immunomodulatory studies that differentiate maternal ingestion during lactation from pregnancy, are needed. Potential herb-drug interaction and other adverse effects should remain central to obstetric advising, but unless a plant is specifically shown as harmful, considering potential contributions to health of individuals and populations, blanket advisories against postpartum herbal use during lactation appear empirically unwarranted.
引用
- Sibeko L, Johns T. Global survey of medicinal plants during lactation and postpartum recovery: Evolutionary perspectives and contemporary health implications. J Ethnopharmacol. 2021. PMID: 33450288. doi:10.1016/j.jep.2021.113812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。